期刊文献+

PON1功能活性在糖尿病合并大血管病变中的预测价值以及多种危险因素对其影响 被引量:3

下载PDF
导出
摘要 目的通过检测不同危险程度的患者血清PON1的活性、PON1蛋白含量和Ox-LDL水平及颈动脉粥样硬化斑块的大小及性质,探讨PON1活性的相关影响因素,以揭示"PON1功能活性"用于糖尿病合并大血管病变患者的风险评估和临床治疗监测的检测靶标的可行性。方法所有入选者入院后立即检测血液,对确诊的糖尿病合并大血管病变患者进行血脂、氧化状态、PON1活性和颈动脉超声等多方面综合分析。结果糖尿病单因素组和多因素组血清TC、TG、LDL-C以及Ox-LDL水平高于正常组,糖尿病单因素组和多因素组PON1酶活性低于正常组,差异均具有统计学意义(P均<0.05),糖尿病组Ox-LDL与PON1酶活性高度负相关(r=-0.73,P<0.05);PON1酶活性与IMT呈显著负相关(r=-0.65,P<0.05)。结论糖尿病合并大血管病变患者PON1的活性越高,Ox-LDL水平越低,颈动脉斑块越稳定,PON1功能活性可以作为预测糖尿病合并大血管病变患者风险评估的新指标。
出处 《现代中西医结合杂志》 CAS 2018年第4期433-435,共3页 Modern Journal of Integrated Traditional Chinese and Western Medicine
关键词 PON1 Ox—LDL 糖尿病
  • 相关文献

参考文献5

二级参考文献77

  • 1刘艾,梅勇,姚刚亮,袁泽.超声检测颈动脉内膜及血管内皮功能与冠心病的相关性[J].兵团医学,2008(4):4-5. 被引量:2
  • 2罗俊,燕纯伯.颈动脉超声对动脉粥样硬化性疾病的研究进展[J].心血管病学进展,2005,26(1):1-4. 被引量:84
  • 3Smith DA,Irving SD,Sheldon J,et al. Interleukin-10 are decreased in patients with unstable angina [J].Circula- tion, 2001,104 (7) : 746-749.
  • 4Baidya SG,Zeng QT, Wang X, et al. T helper cell related interleukins and the angiographic morphology in unstable angina [ J ]. Cytokine, 2005,30(5) : 303-310.
  • 5Fichtlscherer S,Breuer S,Heeschen C,et al. Interleukin- 10 serum levels and systemic endothelial vasoreactivity in patients with coronary artery disease [J]. J Am Coil Car- diol, 2004,44 ( 1 ) : 44-49.
  • 6Dominguez-Rodriguez A. Soluble CD40 ligand:interleukin- 10 ratio predicts in-hospital adverse events in patients with ST-segment elevation myocardial infarction [J]. Thromb Res, 2007,121 (3) : 293-299.
  • 7Yang W,Lu J,Weng J,et al. Prevalence of diabetes a- mong men and women in China [J]. N Engl J Med, 2010,362(12) : 1090-1101.
  • 8Potteaux S, Esposito B, van Oostrom O, et al. Leukocyte- derived interleukin 10 is required for protection against atherosclerosis in low-density lipoprotein receptor knockout mice [J]. Arterioscler Thromb Vasc Biol, 2004,24(8):1474-1478.
  • 9Huang Y,Li T,Sane DC,Li L. IRAK1 serves as a novel regulator essential for lipopolysaccharide-induced inter- leukin-10 gene expression [J]. J Biol Chem,2004,279 (49) :51697-51703.
  • 10Szodoray P,Timar O,Veres K,et al. TH1/TH2 imbal- ance,measured by circulating and intracytoplasmic in- flammatory cytokines--immunological alterations in acute coronary syndrome and stable coronary artery disease [J]. Scand J Immunol, 2006,64 (3) : 336-344.

共引文献30

同被引文献29

引证文献3

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部